IL17A and ventricular tachycardia: The PCL threshold triggering ventricular tachycardia/ventricular fibrillation (VT/VF) was higher in the IL-17 group than in the baseline (IL-17 vs. baseline, 170 ± 20 ms vs. 130 ± 10 ms; P = 0.01) and IL-17 neutralizer groups (IL-17 vs. IL-17 neutralizer, 170 ± 20 vs. 143 ± 5 ms; P = 0.05) (Figure 4E).